Comirnaty - NDC Database
7 records found
Page:
0069-2025 May 18, 2022
Comirnaty .225 mg/2.25ml Intramuscular Injection, Suspension by Pfizer Laboratories Div Pfizer Inc
Comirnaty .225 mg/2.25ml Intramuscular Injection, Suspension by Pfizer Laboratories Div Pfizer Inc
0069-2362 Sep 11, 2023
Comirnaty .048 mg/.48ml Intramuscular Injection, Suspension by Pfizer Laboratories Div Pfizer Inc
Comirnaty .048 mg/.48ml Intramuscular Injection, Suspension by Pfizer Laboratories Div Pfizer Inc
0069-2377 Oct 31, 2023
Comirnaty .042 mg/.418ml Intramuscular Injection, Suspension by Pfizer Laboratories Div Pfizer Inc
Comirnaty .042 mg/.418ml Intramuscular Injection, Suspension by Pfizer Laboratories Div Pfizer Inc
0069-2392 Sep 11, 2023
Comirnaty .043 mg/.432ml Intramuscular Injection, Suspension by Pfizer Laboratories Div Pfizer Inc
Comirnaty .043 mg/.432ml Intramuscular Injection, Suspension by Pfizer Laboratories Div Pfizer Inc
0069-2432 Aug 22, 2024
Comirnaty .042 mg/.418ml Intramuscular Injection, Suspension by Pfizer Laboratories Div Pfizer Inc
Comirnaty .042 mg/.418ml Intramuscular Injection, Suspension by Pfizer Laboratories Div Pfizer Inc
0069-2501 Aug 27, 2025
Comirnaty .0158 mg/.48ml Intramuscular Injection, Suspension by Pfizer Laboratories Div Pfizer Inc
Comirnaty .0158 mg/.48ml Intramuscular Injection, Suspension by Pfizer Laboratories Div Pfizer Inc
0069-2528 Aug 27, 2025
Comirnaty .042 mg/.418ml Intramuscular Injection, Suspension by Pfizer Laboratories Div Pfizer Inc
Comirnaty .042 mg/.418ml Intramuscular Injection, Suspension by Pfizer Laboratories Div Pfizer Inc
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.